Brain Scientific Stock Buy Hold or Sell Recommendation
| BRSF Stock | USD 0.75 0.00 0.00% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Brain Scientific is 'Strong Sell'. Macroaxis provides Brain Scientific buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BRSF positions.
Check out Brain Scientific Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Brain and provide practical buy, sell, or hold advice based on investors' constraints. Brain Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Brain |
Execute Brain Scientific Buy or Sell Advice
The Brain recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Brain Scientific. Macroaxis does not own or have any residual interests in Brain Scientific or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Brain Scientific's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Brain Scientific Trading Alerts and Improvement Suggestions
| Brain Scientific generated a negative expected return over the last 90 days | |
| Brain Scientific has some characteristics of a very speculative penny stock | |
| Brain Scientific currently holds 9.97 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Brain Scientific has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Brain Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Brain Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brain Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brain to invest in growth at high rates of return. When we think about Brain Scientific's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 265.75 K. Net Loss for the year was (9.1 M) with profit before overhead, payroll, taxes, and interest of 83.23 K. | |
| Brain Scientific currently holds about 3.54 M in cash with (5.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 24.0% of Brain Scientific shares are held by company insiders |
Brain Scientific Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Brain Scientific or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Brain Scientific's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Brain pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Brain Scientific Volatility Alert
At this time Brain Scientific exhibits very low volatility. Brain Scientific is a potential penny stock. Although Brain Scientific may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Brain Scientific. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Brain instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Brain Scientific Fundamentals Vs Peers
Comparing Brain Scientific's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Brain Scientific's direct or indirect competition across all of the common fundamentals between Brain Scientific and the related equities. This way, we can detect undervalued stocks with similar characteristics as Brain Scientific or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Brain Scientific's fundamental indicators could also be used in its relative valuation, which is a method of valuing Brain Scientific by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Brain Scientific to competition |
| Fundamentals | Brain Scientific | Peer Average |
| Return On Equity | -45.97 | -0.31 |
| Return On Asset | -1.17 | -0.14 |
| Operating Margin | (28.77) % | (5.51) % |
| Current Valuation | 12.28 M | 16.62 B |
| Shares Outstanding | 105.4 M | 571.82 M |
| Shares Owned By Insiders | 23.83 % | 10.09 % |
| Shares Owned By Institutions | 18.54 % | 39.21 % |
| Price To Sales | 26.56 X | 11.42 X |
| Revenue | 265.75 K | 9.43 B |
| Gross Profit | 83.23 K | 27.38 B |
| EBITDA | (8.32 M) | 3.9 B |
| Net Income | (9.1 M) | 570.98 M |
| Cash And Equivalents | 3.54 M | 2.7 B |
| Cash Per Share | 0.03 X | 5.01 X |
| Total Debt | 9.97 M | 5.32 B |
| Debt To Equity | 0.18 % | 48.70 % |
| Current Ratio | 0.59 X | 2.16 X |
| Book Value Per Share | 0.07 X | 1.93 K |
| Cash Flow From Operations | (5.87 M) | 971.22 M |
| Earnings Per Share | (0.29) X | 3.12 X |
| Number Of Employees | 28 | 18.84 K |
| Beta | -0.88 | -0.15 |
| Market Capitalization | 316.21 M | 19.03 B |
| Total Asset | 13.38 M | 29.47 B |
| Z Score | 18.6 | 8.72 |
| Net Asset | 13.38 M |
Brain Scientific Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Brain . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Brain Scientific Buy or Sell Advice
When is the right time to buy or sell Brain Scientific? Buying financial instruments such as Brain Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Brain Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Diversified Assets Thematic Idea Now
Diversified Assets
Pablicly traded close-end funds and other entities backed by different types of diversified investments. The Diversified Assets theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Diversified Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Brain Pink Sheet
Brain Scientific financial ratios help investors to determine whether Brain Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brain with respect to the benefits of owning Brain Scientific security.